Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited has updated its Securities Trading Policy to ensure compliance with financial market regulations in New Zealand and Australia. This policy is crucial for directors and employees to avoid insider trading and market manipulation, emphasizing the importance of adhering to legal standards to prevent significant penalties.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a wide range of products and services. The company focuses on distributing healthcare, medical, and pharmaceutical products across New Zealand and Australia.
Average Trading Volume: 139,088
Technical Sentiment Signal: Sell
Current Market Cap: A$5.09B
See more data about EBO stock on TipRanks’ Stock Analysis page.